- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/402 - 1-aryl-substituted, e.g. piretanide
Patent holdings for IPC class A61K 31/402
Total number of patents in this class: 466
10-year publication summary
|
28
|
25
|
33
|
26
|
15
|
27
|
21
|
21
|
24
|
20
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Synact Pharma ApS | 25 |
22 |
| Galderma Research & Development | 350 |
16 |
| Ligand Pharmaceuticals Incorporated | 168 |
13 |
| Takeda Pharmaceutical Company Limited | 2698 |
9 |
| F. Hoffmann-La Roche AG | 7796 |
8 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3339 |
8 |
| Bristol-myers Squibb Company | 4757 |
7 |
| Merck Patent GmbH | 5742 |
7 |
| Trustees of Tufts College | 988 |
6 |
| The United States Government AS represented by The Department of Veterans Affairs | 1341 |
6 |
| University of Rochester | 1343 |
6 |
| Novartis AG | 10174 |
5 |
| Conopco, Inc. | 5107 |
5 |
| Nektar Therapeutics | 401 |
5 |
| The Scripps Research Institute | 1345 |
5 |
| The Regents of the University of California | 20868 |
4 |
| Allergan, Inc. | 2155 |
4 |
| Board of Regents of the University of Nebraska | 795 |
4 |
| Children's Medical Center Corporation | 1966 |
4 |
| Hadasit Medical Research Services and Development Ltd. | 323 |
4 |
| Other owners | 318 |